journal article·2024-11-20

Synergistic Integration of α-Ag2WO4 into PLA/PBAT for the Development of Electrospun Membranes: Advancing Structural Integrity and Antimicrobial Efficacy

Marcelo Assis, Gabriela L. Breitenbach, Miguel Martí, Estefanía Sánchez-Safont, Adrian Alfaro-Peyró, Luis Cabedo, Eduardo Garcia-Verdugo, Juan Andrés, Ángel Serrano-Aroca

ACS Applied Materials & Interfaces· Volume 16· Issue 46
Publisher page

Abstract

The rising resistance of various pathogens and the demand for materials that prevent infections drive the need to develop broad-spectrum antimicrobial membranes capable of combating a range of microorganisms, thereby enhancing safety in biomedical and industrial applications. Herein, we introduce a simple and efficient technique to engineer membranes composed of polylactic acid (PLA) and polybutylene adipate terephthalate (PBAT) biopolymers and α-Ag 2 WO 4 particles using an electrospinning technique. The corresponding structural, thermal, mechanical, and antimicrobial properties were characterized. X-ray diffraction (XRD) patterns confirmed the integration of crystalline α-Ag 2 WO 4 within the polymer matrix. Scanning electron microscopy (SEM) and Raman confocal microscopy revealed uniformly dispersed α-Ag 2 WO 4 particles in the electrospun fibers, influencing their diameter and surface roughness. Thermal analysis indicated adjustments in the thermal stability and crystallinity of the composites with an increasing α-Ag 2 WO 4 content. Dynamic mechanical analysis (DMA) highlighted variations in storage modulus and glass transition temperatures due to interactions between α-Ag 2 WO 4 and polymer chains, with tensile tests showing an increase in elastic modulus and ultimate tensile strength as the α-Ag 2 WO 4 content increased. Antimicrobial assessments revealed that PLA/PBAT membranes with α-Ag 2 WO 4 showed pronounced antibacterial activity, forming inhibition halos across all samples against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and Mycobacterium smegmatis (a surrogate for Mycobacterium tuberculosis ). These membranes also exhibited potent antiviral activity against bacteriophage phi 6, a surrogate for SARS-CoV-2, suggesting potential applications in combating infections caused by enveloped viruses. The antimicrobial activities are attributed to the generation of reactive oxygen species (ROS) and the controlled release of Ag + ions. This work underscores the multifaceted capabilities of α-Ag 2 WO 4 -enhanced PLA/PBAT membranes in combating bacterial and viral growth, where both durability and microbial resistance are critical. Taken together, our findings provide a solution for obtaining advanced materials to be applied in a wide range of industrial applications, such as filtration systems, food preservation, antimicrobial coatings, protective textiles, and cleaning products.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Conducting polymers and applications · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomaterials and Bioengineering Lab, Translational Research Centre San Alberto Magno, Catholic University of Valencia San Vicente Mártir (UCV), Valencia 46001, Spain

Department of Inorganic and Organic Chemistry, Universitat Jaume I (UJI), Castelló de la Plana 12071, Spain

Polymers and Advanced Materials Group (PIMA), Universitat Jaume I (UJI), Castelló de la Plana 12071, Spain

Department of Physical and Analytical Chemistry, Universitat Jaume I (UJI), Castelló de la Plana 12071, Spain

Funding

Generalitat Valenciana · Ministerio de Ciencia, Innovación y Universidades · Universitat Jaume I · Universidad Católica de Valencia San Vicente Màrtir

References (70)

Show source-provided references
1. 10.1002/adhm.20140041810.1002/adhm.201400418 ↗
2. 10.1016/j.cej.2024.14874410.1016/j.cej.2024.148744 ↗
3. 10.1002/pat.566010.1002/pat.5660 ↗
4. 10.1016/B978-0-12-816808-0.00016-010.1016/B978-0-12-816808-0.00016-0 ↗
5. 10.1007/12_2010_10610.1007/12_2010_106 ↗
6. 10.3390/polym1207155810.3390/polym12071558 ↗
7. 10.1016/j.msec.2019.11004110.1016/j.msec.2019.110041 ↗
8. 10.3389/fbioe.2022.81446610.3389/fbioe.2022.814466 ↗
9. 10.1007/978-3-031-35205-8_1110.1007/978-3-031-35205-8_11 ↗
10. 10.3390/polym1409166110.3390/polym14091661 ↗
11. 10.3390/ijms2209459510.3390/ijms22094595 ↗
12. 10.1016/j.ijbiomac.2023.12748810.1016/j.ijbiomac.2023.127488 ↗
13. 10.1016/j.actbio.2009.02.00310.1016/j.actbio.2009.02.003 ↗
14. 10.1016/j.memsci.2022.12042610.1016/j.memsci.2022.120426 ↗
15. 10.1016/j.polymdegradstab.2021.10950110.1016/j.polymdegradstab.2021.109501 ↗
16. 10.1016/j.polymertesting.2019.04.01410.1016/j.polymertesting.2019.04.014 ↗
17. 10.3390/polym1503076210.3390/polym15030762 ↗
18. 10.3390/molecules2005885610.3390/molecules20058856 ↗
19. 10.3390/ijms2107237510.3390/ijms21072375 ↗
20. 10.1039/D2RA04667A10.1039/D2RA04667A ↗
21. 10.1155/2021/992075510.1155/2021/9920755 ↗
22. 10.1016/j.reactfunctpolym.2021.10499910.1016/j.reactfunctpolym.2021.104999 ↗
23. 10.3390/biomedicines909115510.3390/biomedicines9091155 ↗
24. 10.1016/j.apcata.2023.11903810.1016/j.apcata.2023.119038 ↗
25. 10.1021/acs.jpcb.1c0522510.1021/acs.jpcb.1c05225 ↗
26. 10.1021/acsomega.2c0620810.1021/acsomega.2c06208 ↗
27. 10.3390/applnano403001210.3390/applnano4030012 ↗
28. 10.3390/biomedicines1106164310.3390/biomedicines11061643 ↗
29. 10.1038/s41598-019-46159-y10.1038/s41598-019-46159-y ↗
30. 10.1038/s41598-018-19270-910.1038/s41598-018-19270-9 ↗
31. 10.1021/acsapm.2c0074410.1021/acsapm.2c00744 ↗
32. 10.1038/s41598-022-11902-510.1038/s41598-022-11902-5 ↗
33. 10.1021/acsapm.3c0301210.1021/acsapm.3c03012 ↗
34. 10.3390/ijms2310533510.3390/ijms23105335 ↗
35. 10.1016/j.ijbiomac.2021.03.17410.1016/j.ijbiomac.2021.03.174 ↗
36. 10.1016/j.jphotobiol.2024.11294710.1016/j.jphotobiol.2024.112947 ↗
37. 10.3791/5771010.3791/57710 ↗
38. 10.1128/JB.187.7.2426-2438.200510.1128/JB.187.7.2426-2438.2005 ↗
39. 10.1021/acsami.2c1946010.1021/acsami.2c19460 ↗
40. https://norgenbiotek.com/sites/default/files/resources/Total-RNA-Purification-Kit-Insert-PI17200-32-M14.pdf (accessed August 10, 2024).
41. 10.1109/TIA.2011.212743110.1109/TIA.2011.2127431 ↗
42. Bartolomei M. R. X. · 2020 · 63110.1007/978-3-030-36628-5_62 ↗
43. 10.1039/D3DT02352D10.1039/D3DT02352D ↗
44. 10.1016/j.materresbull.2023.11225210.1016/j.materresbull.2023.112252 ↗
45. 10.1016/j.molliq.2020.11447610.1016/j.molliq.2020.114476 ↗
46. 10.1590/s1517-707620220002.138110.1590/s1517-707620220002.1381 ↗
47. 10.1016/j.matlet.2021.13088110.1016/j.matlet.2021.130881 ↗
48. 10.1039/C5DT01997D10.1039/C5DT01997D ↗
49. 10.3390/polym1403037910.3390/polym14030379 ↗
50. 10.1007/s10924-012-0534-210.1007/s10924-012-0534-2 ↗
51. 10.1016/j.msec.2014.02.02010.1016/j.msec.2014.02.020 ↗
52. 10.3390/molecules17101172910.3390/molecules171011729 ↗
53. 10.1016/j.polymertesting.2015.02.00510.1016/j.polymertesting.2015.02.005 ↗
54. 10.1016/j.compscitech.2009.02.02210.1016/j.compscitech.2009.02.022 ↗
55. 10.1016/j.polymertesting.2013.05.00110.1016/j.polymertesting.2013.05.001 ↗
56. 10.1007/s00289-016-1798-910.1007/s00289-016-1798-9 ↗
57. 10.1016/j.gendis.2019.04.00110.1016/j.gendis.2019.04.001 ↗
58. 10.3390/antibiotics1105060610.3390/antibiotics11050606 ↗
59. 10.1016/j.jiph.2020.06.02310.1016/j.jiph.2020.06.023 ↗
60. https://www.who.int/news-room/fact-sheets/detail/tuberculosis (accessed August 10, 2024).
61. 10.2147/IJN.S24118310.2147/IJN.S241183 ↗
62. 10.1016/j.jece.2024.11393510.1016/j.jece.2024.113935 ↗
63. 10.3390/polym1407148310.3390/polym14071483 ↗
64. 10.1016/j.eurpolymj.2023.11237710.1016/j.eurpolymj.2023.112377 ↗
65. 10.1021/acs.cgd.0c0141710.1021/acs.cgd.0c01417 ↗
66. 10.3390/nano1219331610.3390/nano12193316 ↗
67. 10.1016/j.bioadv.2022.21309710.1016/j.bioadv.2022.213097 ↗
68. 10.1159/00002982010.1159/000029820 ↗
69. 10.1034/j.1600-0765.2001.360207.x10.1034/j.1600-0765.2001.360207.x ↗
70. 10.1007/s13726-014-0258-310.1007/s13726-014-0258-3 ↗